Group K Diagnostics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $655K
Latest Deal Amount
  • Investors
  • 8

Group K Diagnostics General Information

Description

Developer of point-of-care diagnostic tests designed to improve the patient care cycle and also cut costs. The company leverages paper or wax-based microfluidics technology for point-of-care testing and fast results across a suite of various diagnostics, providing clinicians with greater transparency, immediate results, and maximum accessibility.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 1015 Chestnut Street
  • Suite 1010
  • Philadelphia, PA 19107
  • United States
+1 (267) 000-0000

Group K Diagnostics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Group K Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC 30-Jul-2020 $655K 00.000 Completed Clinical Trials - General
8. Debt - PPP 10-Apr-2020 00000 00.000 Completed Clinical Trials - General
7. Early Stage VC 26-Aug-2019 00000 00.000 Completed Clinical Trials - General
6. Early Stage VC (Series A) 29-Nov-2018 00.000 00.00 Completed Clinical Trials - General
5. Seed Round 01-Nov-2017 00000 00000 Completed Clinical Trials - General
4. Accelerator/Incubator 27-Mar-2017 Completed Pre-Clinical Trials
3. Accelerator/Incubator 20-Mar-2017 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2017 Completed Startup
1. Grant 02-Dec-2016 Completed Startup
To view Group K Diagnostics’s complete valuation and funding history, request access »

Group K Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of point-of-care diagnostic tests designed to improve the patient care cycle and also cut costs. The company l
Diagnostic Equipment
Philadelphia, PA
9 As of 2021
00.000
0000000000 0 00.000

00000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000000000 000000000
Salem, MA
0000000000

000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
0000000000 000000000
Union City, CA
000 As of 0000
000.00
0.000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Group K Diagnostics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Diagnostics For All Corporation Salem, MA 0000000000
000000 Formerly VC-backed Union City, CA 000 000.00 000000&0 000.00
000000 00000 00 00 Corporate Backed or Acquired Princeton, NJ 0000 000000&0
00000 0000000 Corporation Basel, Switzerland 000000 00000 00000000000
To view Group K Diagnostics’s complete competitors history, request access »

Group K Diagnostics Executive Team (5)

Name Title Board Seat Contact Info
Brianna Wronko Co-Founder, Chief Executive Officer & Chairwoman
Darren Aversa Controller Consultant
You’re viewing 2 of 5 executive team members. Get the full list »

Group K Diagnostics Board Members (4)

Name Representing Role Since
Brianna Wronko Group K Diagnostics Co-Founder, Chief Executive Officer & Chairwoman 000 0000
Jay Rosan Group K Diagnostics Board Member 000 0000
Paul Farr Group K Diagnostics Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Group K Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Group K Diagnostics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioAdvance Venture Capital Minority 000 0000 000000 0
Lehigh Valley Angel Investors Angel Group Minority 000 0000 000000 0
University of Pennsylvania Endowment Limited Partner Minority 000 0000 000000 0
Dreamit Ventures Accelerator/Incubator Minority 000 0000 000000 0
Wharton Venture Initiation Program Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »